1-3 of 3
Kim Hartig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial Of Bortezomib In Combination With Fractionated Cyclophosphamide and Rituximab (BCR) For Relapsed/Refractory Mantle Cell Lymphoma (MCL)

Free
Jorge E Romaguera, MD, Michelle A. Fanale, MD, Felipe Samaniego, M.D., M.P.H, Luis E Fayad, Fredrick B Hagemeister, MD, Peter McLaughlin, MD, Maria Alma Rodriguez, MD, Pam Weaver, Kim Hartig, Maria Badillo, BS, Larry W. Kwak, MD, PhD, Anas Younes, MD, Barbara Pro, MD, Michael Wang, MD
Journal: Blood
Blood (2013) 122 (21): 5122.
https://doi.org/10.1182/blood.V122.21.5122.5122
Published: 2013
Journal Articles

Rituximab (R) + Hypercvad Alternating with R-Methotrexate/Cytarabine after 9 Years: Continued High Rate of Failure-Free Survival in Untreated Mantle Cell Lymphoma (MCL)

Free
Jorge Romaguera, Luis Fayad, Alma Rodriguez, Fb Hagemeister, Barbara Pro, Peter McLaughlin, Anas Younes, Felipe Samaniego, Jatin Shah, Pamela Weaver, Kim Hartig, Fernando Cabanillas, Larry Kwak, Hagop Kantarjian, Michael Wang
Journal: Blood
Blood (2008) 112 (11): 833.
https://doi.org/10.1182/blood.V112.11.833.833
Published: 2008
Journal Articles

Lenalidomide (Len) in Combination with Rituximab (R) Demonstrated Early Evidence of Efficacy in a Phase I/II Study in Relapsed/Refractory Mantle Cell Lymphoma (MCL).

Free
Michael Wang, MD, Luis Fayad, MD, Frederick Hagemeister, MD, Sattva Neelapu, MD, Barry Samuels, MD, Felipe Samanigo, MD, Barbara Pro, MD, Qing Yi, MD, PhD, Neda Bell, Catriona Byrne, Pam Weaver, Kim Hartig, Robert Knight, MD, Jerry Zeldis, MD, Larry Kwak, MD, PhD, Jorge Romaguera, MD
Journal: Blood
Blood (2007) 110 (11): 2562.
https://doi.org/10.1182/blood.V110.11.2562.2562
Published: 2007